Axio Biosolutions

Bengaluru, Karnataka, India · Cambridge, MA, USA +4

4 open jobsBiomaterialsBiotechBusiness And IndustrialEmergency MedicineGovernment and MilitaryHardwareHealth CareHealthcareInformation TechnologyManufacturingManufacturing & IndustrialMedicalMedical DevicesMedical Equipment ManufacturingMilitaryPharmaceuticals

Open roles

4

Stage

series-b

Employees

51–200

Backed by

Accel

Axio is a MedTech R&D and Manufacturing Company focused on Advanced Surgical and Wound Care. Axio has the distinction of being the first company from India to get USFDA clearance for a Wound Care/Hemostat product. Controlling life-threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat is its flagship product developed to reduce mortality due to traumatic bleeding. A CE approved product, Axiostat is based on a patented novel 100% chitosan platform and has variants catering to Emergency & Trauma, Military, Cardiovascular, and Dental applications.